Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Moffitt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|February 22, 2011
Characterisation of the FAM69 family of cysteine-rich endoplasmic reticulum proteinsAnthea J Tennant-Eyles, Hilary Moffitt, Caroline A Whitehouse, et al.
Plos One|December 4, 2009
Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's diseaseHilary Moffitt, Graham D McPhail, Ben Woodman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
DNA instability in postmitotic neuronsRoman Gonitel, Hilary Moffitt, Kirupa Sathasivam, et al.
Plos One|June 2, 2009
Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's diseaseCaroline L Benn, Rachel Butler, Lydia Mariner, et al.
Brain Research Bulletin|March 14, 2007
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypesBen Woodman, Rachel Butler, Christian Landles, et al.
Kidney International Reports|November 9, 2019
Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal ImpairmentNicholas R Medjeral-Thomas, Hilary Moffitt, Hannah J Lomax-Browne, et al.
The Journal of Biological Chemistry|January 21, 2010
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington diseaseChristian Landles, Kirupa Sathasivam, Andreas Weiss, et al.
Neurobiology of Disease|August 23, 2005
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's diseaseEmma Hockly, Jamie Tse, Amy L Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2010
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisRuth Luthi-Carter, David M Taylor, Judit Pallos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|February 22, 2011
Characterisation of the FAM69 family of cysteine-rich endoplasmic reticulum proteinsAnthea J Tennant-Eyles, Hilary Moffitt, Caroline A Whitehouse, et al.
Plos One|December 4, 2009
Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's diseaseHilary Moffitt, Graham D McPhail, Ben Woodman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
DNA instability in postmitotic neuronsRoman Gonitel, Hilary Moffitt, Kirupa Sathasivam, et al.
Plos One|June 2, 2009
Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's diseaseCaroline L Benn, Rachel Butler, Lydia Mariner, et al.
Brain Research Bulletin|March 14, 2007
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypesBen Woodman, Rachel Butler, Christian Landles, et al.
Kidney International Reports|November 9, 2019
Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal ImpairmentNicholas R Medjeral-Thomas, Hilary Moffitt, Hannah J Lomax-Browne, et al.
The Journal of Biological Chemistry|January 21, 2010
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington diseaseChristian Landles, Kirupa Sathasivam, Andreas Weiss, et al.
Neurobiology of Disease|August 23, 2005
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's diseaseEmma Hockly, Jamie Tse, Amy L Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2010
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisRuth Luthi-Carter, David M Taylor, Judit Pallos, et al.
Pageof 1